Additional file 5: of Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4â5 chronic kidney disease: a systematic review and meta-analysis

Li, Mingshu; Chen, Jun; Fang, Zhixiong; Li, Yi; Lin, Qian

doi:10.6084/m9.figshare.7850459.v1

12985_2019_1140_MOESM5_ESM.pdf (7.17 kB)

Additional file 5: of Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4â5 chronic kidney disease: a systematic review and meta-analysis

journal contribution

posted on 2019-03-14, 05:00 authored by Mingshu Li, Jun Chen, Zhixiong Fang, Yi Li, Qian Lin

Figure S5. Forest plots showing the results of subgroup analysis result of SVR12/24 in patients originated from Asia, North America and Europe. (PDF 7 kb)

History

Usage metrics

Keywords

HCV infection Stage 4â5 chronic kidney disease Sofosbuvir Dose Meta-analysis

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC